Medical devices, healthcare technology and the business of care
510(k) clearance · K262553

MOBILITY SCOOTER (YQ-401,YQ- 401A,YQ-403,YQ-403A)

Zhejiang Kailang Technology Co., Ltd. · Decision date Sep 29, 2026

MEDTECHLEDGER EXPLANATIONK262553

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-29 for K262553, a traditional 510(k) submitted by Zhejiang Kailang Technology Co., Ltd. of Yongkang, CN, received 07/24/2026. The device is listed as MOBILITY SCOOTER (YQ-401, YQ-401A, YQ-403, YQ-403A), classified under product code INI as a motorized 3-wheeled vehicle, regulation 890.3800, in the Physical Medicine specialty and review panel. SESE means clearance to market, not PMA approval.

The record shows no third-party review, no combination product designation and no authorized predetermined change control plan. The page does not identify a predicate device, summarize performance testing, or describe any component-level change, so the technical basis for the equivalence finding is not available here. The applicant's consultant is listed in Shanghai, CN.

The public record is limited to administrative fields; it does not establish clinical performance, labeling content or postmarket obligations for these scooter models.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Sep 29, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262553
Regulatory pathway
510(k) premarket notification
Product code
INI
Decision code
SESE
Decision date
Sep 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Vehicle, Motorized 3-Wheeled.

Product code
INI
FDA device class
2

FDA decision timeline

  1. K262553 received

    Application receipt date recorded by FDA.

  2. K262553 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code INI

Product / regulatory recordCompanyPathwayDecision dateSource
Nanjing Mijo Technology Co., Ltd.510(k) clearanceSep 29, 2026FDA
Anhui JBH Medical Apparatus Co., Ltd.510(k) clearanceSep 24, 2026FDA
Anhui JBH Medical Apparatus Co., Ltd.510(k) clearanceSep 19, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zhejiang Kailang Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yongkang

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records